AAAAAA
Results: 1-25/64
Authors:
Schmid, P
Possinger, K
Citation: P. Schmid et K. Possinger, Liposomal anthracyclines for improved cardiac tolerability, BREAST, 10, 2001, pp. 22-27
Authors:
Gion, M
Mione, R
Leon, AE
Luftner, D
Molina, R
Possinger, K
Robertson, JF
Citation: M. Gion et al., CA27.29: a valuable marker for breast cancer management. A confirmatory multicentric study on 603 cases, EUR J CANC, 37(3), 2001, pp. 355-363
Authors:
Genvresse, I
Lange, C
Schanz, J
Schweigert, M
Harder, H
Possinger, K
Spath-Schwalbe, E
Citation: I. Genvresse et al., Tolerability of the cytoprotective agent amifostine in elderly patients receiving chemotherapy: a comparative study, ANTI-CANC D, 12(4), 2001, pp. 345-349
Authors:
Sezer, O
Niemoller, K
Jakob, C
Zavrski, I
Heider, U
Eucker, J
Kaufmann, O
Possinger, K
Citation: O. Sezer et al., Relationship between bone marrow angiogenesis and plasma cell infiltrationand serum beta 2-microglobulin levels in patients with multiple myeloma, ANN HEMATOL, 80(10), 2001, pp. 598-601
Authors:
Eucker, J
Sezer, O
Graf, B
Possinger, K
Citation: J. Eucker et al., Mucormycoses, MYCOSES, 44(7-8), 2001, pp. 253-260
Authors:
Zamboni, WC
Luftner, DI
Egorin, MJ
Schweigert, M
Sezer, O
Richter, T
Natale, JJ
Possinger, K
Citation: Wc. Zamboni et al., The effect of increasing topotecan infusion from 30 minutes to 4 hours on the duration of exposure in cerebrospinal fluid, ANN ONCOL, 12(1), 2001, pp. 119-122
Authors:
Sezer, O
Niemoller, K
Kaufmann, O
Eucker, J
Jakob, C
Zavrski, I
Possinger, K
Citation: O. Sezer et al., Decrease of bone marrow angiogenesis in myeloma patients achieving a remission after chemotherapy, EUR J HAEMA, 66(4), 2001, pp. 238-244
Authors:
Sezer, O
Jakob, C
Eucker, J
Niemoller, K
Gatz, F
Wernecke, KD
Possinger, K
Citation: O. Sezer et al., Serum levels of the angiogenic cytokines basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in multiple myeloma, EUR J HAEMA, 66(2), 2001, pp. 83-88
Authors:
Luftner, D
Bollow, M
Sturzenbecher, A
Kaufmann, O
Priem, F
Richter, A
Gunther, S
Geppert, R
Petrides, PE
Wernecke, KD
Possinger, K
Citation: D. Luftner et al., Biomarkers and imaging in non-malignant and malignant osteomalacia, INT J B MAR, 16(2), 2001, pp. 136-141
Authors:
Sezer, O
Heider, U
Zavrski, I
Possinger, K
Citation: O. Sezer et al., Differentiation of monoclonal gammopathy of undetermined significance and multiple myeloma using flow cytometric characteristics of plasma cells, HAEMATOLOG, 86(8), 2001, pp. 837-843
Authors:
Kopp, R
Classen, S
Wolf, H
Gholam, P
Possinger, K
Eiermann, W
Wilmanns, W
Citation: R. Kopp et al., Predictive relevance of soluble CD44v6 serum levels for the responsivenessto second line hormone- or chemotherapy in patients with metastatic breastcancer, ANTICANC R, 21(4B), 2001, pp. 2995-3000
Authors:
Sezer, O
Eucker, J
Jakob, C
Kaufmann, O
Schmid, P
Possinger, K
Citation: O. Sezer et al., Achievement of complete remission in refractory Hodgkin's disease with prolonged infusion of gemcitabine, INV NEW DR, 19(1), 2001, pp. 101-104
Authors:
Junker, A
Illiger, HJ
Possinger, K
Wiedemann, GJ
Citation: A. Junker et al., The importance of aromatase inhibition in the treatment of mammery carcinoma. A critical comparison of pharmacological and clinical facts, GYNAKOLOGE, 34(7), 2001, pp. 664-668
Authors:
Wischnewsky, MB
Schmid, P
Possinger, K
Bohm, R
Chaudry, HA
Citation: Mb. Wischnewsky et al., Who benefits most from second-line treatment with letrozole?, AROMATASE INHIBITION AND BREAST CANCER, 2001, pp. 63-84
Authors:
Sezer, O
Niemoller, K
Jakob, C
Langelotz, C
Eucker, J
Possinger, K
Citation: O. Sezer et al., Novel approaches to the treatment of primary amyloidosis, EXPERT OP I, 9(10), 2000, pp. 2343-2350
Authors:
Sezer, O
Langelotz, C
Blohmer, JU
Schmid, P
Akrivakis, K
Possinger, K
Citation: O. Sezer et al., Detection of HMGI-C in the peripheral blood of breast cancer patients, EUR J CANC, 36(15), 2000, pp. 1944-1948
Authors:
Spath-Schwalbe, E
Genvresse, I
Koschuth, A
Dietzmann, A
Grunewald, R
Possinger, K
Citation: E. Spath-schwalbe et al., Phase II trial of gemcitabine in patients with pretreated advanced soft tissue sarcomas, ANTI-CANC D, 11(5), 2000, pp. 325-329
Authors:
Genvresse, I
Spath-Schwalbe, E
Meisel, H
Kaufmann, O
Kruger, DH
Possinger, K
Citation: I. Genvresse et al., Primary hepatic or splenic diffuse large B-cell lymphoma and hepatitis C virus infection: a non-fortuitous association?, ANN HEMATOL, 79(9), 2000, pp. 530-532
Authors:
Spath-Schwalbe, E
Flath, B
Kaufmann, O
Thiel, G
Brinckmann, R
Dietel, M
Possinger, K
Citation: E. Spath-schwalbe et al., An unusual case of leukemic non-Hodgkin's lymphoma with blastic transformation, ANN HEMATOL, 79(4), 2000, pp. 217-221
Authors:
Sezer, O
Eucker, J
Bauhuis, C
Schweigert, M
Luftner, D
Kalus, U
Spath-Schwalbe, E
Arnold, R
Possinger, K
Citation: O. Sezer et al., Patients with malignant lymphomas experience a higher rate of documented infections than patients with breast cancer after high-dose chemotherapy with autologous peripheral stem cell transplantation, ANN HEMATOL, 79(11), 2000, pp. 627-630
Authors:
Harder, H
Eucker, J
Zang, C
Possinger, K
Muller-Hocker, J
Beutler, E
Petrides, PE
Citation: H. Harder et al., Coincidence of Gaucher's disease due to a 1226G/1448C mutation and of an immunoglobulin G lambda multiple myeloma with Bence-Jones proteinuria, ANN HEMATOL, 79(11), 2000, pp. 640-643
Authors:
Sezer, O
Niemoller, K
Eucker, J
Jakob, C
Kaufmann, O
Zavrski, I
Dietel, M
Possinger, K
Citation: O. Sezer et al., Bone marrow microvessel density is a prognostic factor for survival in patients with multiple myeloma, ANN HEMATOL, 79(10), 2000, pp. 574-577
Authors:
Sezer, O
Eucker, J
Schmid, P
Possinger, K
Citation: O. Sezer et al., New therapeutic approaches in primary systemic AL amyloidosis, ANN HEMATOL, 79(1), 2000, pp. 1-6
Authors:
Heinemann, V
Wilke, H
Mergenthaler, HG
Clemens, M
Konig, H
Illiger, HJ
Arning, M
Schalhorn, A
Possinger, K
Fink, U
Citation: V. Heinemann et al., Gemcitabine and cisplatin in the treatment of advanced or metastatic pancreatic cancer, ANN ONCOL, 11(11), 2000, pp. 1399-1403
Authors:
Genvresse, I
Buttgereit, F
Spath-Schwalbe, E
Ziemer, S
Eucker, J
Possinger, K
Citation: I. Genvresse et al., Arterial thrombosis associated with anticardiolipin and anti-beta 2-glycoprotein-I antibodies in patients with non-Hodgkin's lymphoma: a report of two cases, EUR J HAEMA, 65(5), 2000, pp. 344-347